Sandoz Ups Biosimilar Game With Alteogen Subcutaneous Tech Deal

Alteogen Comments Suggests Deal Worth Up To $145m

 
• By Dean Rudge
Alliance
Alteogen is also developing a biosimilar eylea product • Source: Shutterstock

More from Biosimilars

More from Products